Granted IMC-G.A.P. Equivalency Certification by Control Union (“CU”)Milestone to export to Israel and EU-GMP facilities in ...

Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...

With the thumbs up from CHMP, the Opvido-Yervoy combo now moves forward to the European Commission ... from the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA).

Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

Both the US Food and Drug Administration (FDA), through the Orphan Drug Act, and the European Medicines Agency (EMA), through ... alongside the International Rare Diseases Research Consortium ...

International reliance is a mechanism ... accordingly announced that from 2024 the Medicines and Healthcare products Regulatory Agency (MHRA) will adopt a new regulatory model, allowing for ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, ...

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

Talks cement a relationship between UEFA, Europe’s leading clubs and an agency that wants to stage European club football in ...

It has been more than a decade since the NHL last participated in the Olympics and almost nine years since the league’s top players took part in an international tournament. That wait is about ...